The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The importance of plasma protein binding in drug discovery
Abstract
Plasma protein binding of drugs is a well-recognised phenomena, but it is only recently that the implications for drug action in vivo have been fully appreciated. Plasma proteins, by virtue of their high concentration, control the free drug concentration in plasma and in compartments in equilibrium with plasma, thereby, effectively attenuating drug potency in vivo. The historical background and thermodynamic basis for the 'Free Drug Principle' is presented, along with special considerations for intracellular targets, deep compartments and α1-acid glycoprotein binding. Real and apparent exceptions to the principle are discussed along with a survey of citations from the recent medicinal chemistry literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Albumin: Biochemical properties and therapeutic potential†
Quinlan, G. J., Martin, G. S., & Evans, T. W. (2005) · Hepatology · doi:10.1002/hep.20720 · Cited by 984
The renin-angiotensin-aldosterone system: Past, present and future
Vecsei, P., Hackenthal, E., & Ganten, D. (1978) · Klinische Wochenschrift · doi:10.1007/bf01477448 · Cited by 604
Drug binding to human alpha-1-acid glycoprotein in health and disease.
Kremer, J. M., Wilting, J., & Janssen, L. H. (1988) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00015-8 · Cited by 583
Predicting plasma protein binding of drugs: a new approach
Kratochwil, N. A., Huber, W., Müller, F., Kansy, M., & Gerber, P. R. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01074-2 · Cited by 553
Cory Kalvass, J., & Maurer, T. S. (2002) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.325 · Cited by 412
Weisiger, R., Gollan, J., & Ockner, R. (1981) · Science · doi:10.1126/science.6258226 · Cited by 382
HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
Israili, Z. H., & Dayton, P. G. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100104402 · Cited by 367
Gambacorti-Passerini, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1641 · Cited by 320
Nozawa, T., Minami, H., Sugiura, S., Tsuji, A., & Tamai, I. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001909 · Cited by 316
Chapter 33. Plasma Protein Binding of Drugs
Olson, R. E., & Christ, D. D. (1996) · Annual Reports in Medicinal Chemistry · doi:10.1016/s0065-7743(08)60472-8 · Cited by 303
Therapeutic Drug Monitoring in Saliva
Danhof, M., & Breimer, D. D. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803010-00003 · Cited by 295
Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Sausville, E. A., Arbuck, S. G., Messmann, R., Headlee, D., Bauer, K. S., Lush, R. M., Murgo, A., Figg, W. D., Lahusen, T., Jaken, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2319 · Cited by 291
Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
Gambacorti-Passerini, C. B., Zucchetti, M., Russo, D., Frapolli, R., Verga, M., Bungaro, S., Tornaghi, L., Rossi, F., Pioltelli, P. E., Pogliani, E., et al. (2003) · PubMed · Cited by 226
Drug Uptake Systems in Liver and Kidney
van Montfoort, J., Hagenbuch, B., Groothuis, G., Koepsell, H., Meier, P., & Meijer, D. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489460 · Cited by 221
Maurer, T. S., DeBartolo, D. B., Tess, D. A., & Scott, D. O. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001222 · Cited by 214
Methods of Determining Plasma and Tissue Binding of Drugs: Pharmacokinetic Consequences
Pacifici, G. M., & Viani, A. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223060-00005 · Cited by 208
Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation
Gestwicki, J. E., Crabtree, G. R., & Graef, I. A. (2004) · Science · doi:10.1126/science.1101262 · Cited by 200
Fuse, E., Tanii, H., Kurata, N., Kobayashi, H., Shimada, Y., Tamura, T., Sasaki, Y., Tanigawara, Y., Lush, R. D., Headlee, D. J., et al. (1998) · PubMed · Cited by 200
Balani, S., Miwa, G., Gan, L.-S., Wu, J.-T., & Lee, F. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802605774297038 · Cited by 185
Therapeutic Drug Monitoring in Saliva: An Update
Drobitch, R. K., & Svensson, C. K. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199223050-00003 · Cited by 184
Summerfield, S. G., Stevens, A. J., Cutler, L., del Carmen Osuna, M., Hammond, B., Tang, S.-P., Hersey, A., Spalding, D. J., & Jeffrey, P. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092916 · Cited by 175
Clinical Relevance of P-Glycoprotein in Drug Therapy
Lin, J. H., & Yamazaki, M. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026871 · Cited by 167
3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 1. Lead Finding
Pevarello, P., Brasca, M. G., Amici, R., Orsini, P., Traquandi, G., Corti, L., Piutti, C., Sansonna, P., Villa, M., Pierce, B. S., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031145u · Cited by 162
Zur Plasmaproteinbindung von Arzneimitteln
Krieglstein, J. (1969) · Journal of Molecular Medicine · doi:10.1007/bf01483741 · Cited by 144
Corbett, J. W., Ko, S. S., Rodgers, J. D., Jeffrey, S., Bacheler, L. T., Klabe, R. M., Diamond, S., Lai, C., Rabel, S. R., Saye, J. A., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2893 · Cited by 129
Self-citationHeron, N. M., Anderson, M., Blowers, D. P., Breed, J., Eden, J. M., Green, S., Hill, G. B., Johnson, T., Jung, F. H., McMiken, H. H. J., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.053 · Cited by 128
Cowart, M., Faghih, R., Curtis, M. P., Gfesser, G. A., Bennani, Y. L., Black, L. A., Pan, L., Marsh, K. C., Sullivan, J. P., Esbenshade, T. A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040118g · Cited by 122
Wan, H., & Rehngren, M. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.10.030 · Cited by 122
Edmondson, S. D., Mastracchio, A., Mathvink, R. J., He, J., Harper, B., Park, Y., Beconi, M. G., Salvo, J. D., Eiermann, G. J., He, H., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060015t · Cited by 120
Hervé, F., Caron, G., Duché, J.-C., Gaillard, P., Rahman, N. A., Tsantili‐Kakoulidou, A., Carrupt, P., d’Athis, P., Tillement, J. P., & Testa, B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.129 · Cited by 116
Ljung, B., Bamberg, K., Dahllöf, B., Kjellstedt, A., Oakes, N. D., Östling, J., Svensson, L., & Camejo, G. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200127-jlr200 · Cited by 115
Review of UCN‐01 Development: A Lesson in the Importance of Clinical Pharmacology
Fuse, E., Kuwabara, T., Sparreboom, A., Sausville, E. A., & Figg, W. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274549 · Cited by 113
α 1 ‐Acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis
Hashimoto, S., Asao, T., Takahashi, J., Yagihashi, Y., Nishimura, T., Saniabadi, A. R., Poland, D. C. W., van Dijk, W., Kuwano, H., Kochibe, N., et al. (2004) · Cancer · doi:10.1002/cncr.20713 · Cited by 112
Computational prediction of the plasma protein‐binding percent of diverse pharmaceutical compounds
Yamazaki, K., & Kanaoka, M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20059 · Cited by 112
Tran, A., Rey, E., Pons, G., Rousseau, M., d’Athis, P., Olivé, G., MATHER, G. G., Bishop, F. E., Wurden, C. J., Labroo, R. B., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90044-8 · Cited by 110
Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?
Peters, T. S. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522121 · Cited by 98
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.
Jones, D. R., Hall, S. D., Jackson, E. K., Branch, R. A., & Wilkinson, G. R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24108-8 · Cited by 88
Rational Design of Diflunisal Analogues with Reduced Affinity for Human Serum Albumin
Mao, H., Hajduk, P. J., Craig, R., Bell, R., Borre, T., & Fesik, S. W. (2001) · Journal of the American Chemical Society · doi:10.1021/ja015955b · Cited by 87
Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Lin, J. H. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832578 · Cited by 85
Jørgensen, H. G., Elliott, M. A., Allan, E. K., Carr, C. E., Holyoake, T. L., & Smith, K. D. (2002) · Blood · doi:10.1182/blood.v99.2.713 · Cited by 85
Design of a potent, soluble glucokinase activator with excellent in vivo efficacy
McKerrecher, D., Allen, J. V., Caulkett, P. W. R., Donald, C. S., Fenwick, M. L., Grange, E., Johnson, K. M., Johnstone, C., Jones, C. D., Pike, K. G., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.022 · Cited by 85
Microdialysis for pharmacokinetic analysis of drug transport to the brain
de Lange, E. C. M., de Boer, B. G., & Breimer, D. D. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00089-1 · Cited by 81
Hervé, F., Gomas, E., Jc, D., & Tillement, J. P. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb04224.x · Cited by 79
Bilello, J. A., Bilello, P., Stellrecht, K. A., Leonard, J. M., Norbeck, D. W., Kempf, D. J., Robins, T., & Drusano, G. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1491 · Cited by 78
Deguchi, Y., Nozawa, K., Yamada, S., Yokoyama, Y., & Kimura, R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36456-0 · Cited by 77
Biotechnology: Pharmaceutical Aspects
Ranade, V. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817c947a · Cited by 72
Larghero, J., Leguay, T., Mourah, S., Madelaine, I., Taksin, A., Raffoux, E., Bastie, J.-N., Degos, L., Berthaud, P., Marolleau, J., et al. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00469-6 · Cited by 71
Intracellular Accumulation of Human Immunodeficiency Virus Protease Inhibitors
Khoo, S., Hoggard, P. G., Williams, I. G., Meaden, E. R., Newton, P. J., Wilkins, E. G. L., Smith, A. M., Tjia, J. F., Lloyd, J., Jones, K., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3228-3235.2002 · Cited by 71
Pei, Z., Li, X., Longenecker, K. L., von Geldern, T. W., Wiedeman, P. E., Lubben, T. H., Zinker, B. A., Stewart, K. D., Ballaron, S. J., Stashko, M. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051283e · Cited by 67
Role of Site-Specific Binding to Plasma Albumin in Drug Availability to Brain
Mandula, H., Parepally, J. M. R., Feng, R., & Smith, Q. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097402 · Cited by 66
Li, Y.-W., Hill, G. R., Wong, H. H., Kelly, N., Ward, K., Pierdomenico, M., Ren, S. X., Gilligan, P. J., Grossman, S. J., Trainor, G. L., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045914 · Cited by 63
Self-citationEdwards, J. E., Brouwer, K. R., & McNamara, P. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2284-2286.2002 · Cited by 63
Tang, C., Lin, Y. J., Rodrigues, A. D., & Lin, J. H. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.648 · Cited by 60
Gunturi, S. B., Ramamurthi, N., & Khandelwal, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.02.008 · Cited by 48
Eskild, W., Kindberg, G. M., Smedsrød, B. H., Blomhoff, R., Norum, K. R., & Berg, T. (1989) · Biochemical Journal · doi:10.1042/bj2580511 · Cited by 45
Cimitan, S., Lindgren, M. T., Bertucci, C., & Danielson, U. H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049343o · Cited by 44
Terasaki, T., Pardridge, W. M., & Denson, D. D. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23369-9 · Cited by 41
Binding of imatinib by α1-acid glycoprotein
Gambacorti-Passerini, C. B., le Coutre, P., Zucchetti, M., & D’Incalci, M. (2002) · Blood · doi:10.1182/blood-2002-02-0518 · Cited by 38
SC-52151, a novel inhibitor of the human immunodeficiency virus protease
Bryant, M. L., Getman, D. P., Smidt, M. L., Marr, J. J., Clare, M., Dillard, R. F., Lansky, D. M., DeCrescenzo, G. A., Heintz, R., & Houseman, K. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2229 · Cited by 38
Influence of serum protein binding on theIn Vitro activity of anti-fungal agents
Schäfer‐Korting, M., Körting, H. C., Rittler, W., & Obermüller, W. (1995) · Infection · doi:10.1007/bf01716289 · Cited by 36
Jones, K., Hoggard, P. G., Khoo, S., Maher, B., & Back, D. J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01324.x · Cited by 36
The Role of Plasma-binding Proteins in the Cellular Uptake of Lipophilic Vitamins and Steroids
Andreassen, T. T. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-925348 · Cited by 35
High-Throughput Physicochemical and In Vitro ADMET Screening: A Role in Pharmaceutical Profiling
Valko, K. L., & Reynolds, D. P. (2005) · American Journal of Drug Delivery · doi:10.2165/00137696-200503020-00002 · Cited by 28
Wong, H. H., Grossman, S. J., Bai, S. A., Diamond, S., Wright, M. R., Grace, J. E., Qian, M., He, K., Yeleswaram, K., & Christ, D. D. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000943 · Cited by 27
Liu, J., Liu, Y., Li, Y., Pan, D., & Hopfinger, A. J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.035 · Cited by 26
Copeland, R. A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1000::aid-jps4>3.0.co;2-1 · Cited by 26
Liu, J., Liu, Y., Li, Y., Pan, D., & Hopfinger, A. J. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-9012-4 · Cited by 20
Willis, C. L., Brazell, C., & Foster, A. C. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90441-r · Cited by 19
Rusnak, D. W., Lai, Z., Lansing, T. J., Rhodes, N., Gilmer, T. M., & Copeland, R. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.103 · Cited by 18
Pimpaneau, V., Midoux, P., Durand, G., BAETSELIER, P. D., Monsigny, M. L. P., & Roche, A. (1989) · Glycoconjugate Journal · doi:10.1007/bf01053778 · Cited by 18
Rajaraman, G., Roberts, M. S., Hung, D. Y., Wang, G. Q., & Burczynski, F. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7248-2 · Cited by 12
DuP 532, an angiotensin II receptor antagonist: First administration and comparison with losartan*
Goldberg, M. R., Lo, M., Christ, D. D., Chiou, R. H.-Y., Furtek, C. I., Amit, O., Carides, A. D., Biollaz, J., Piguet, V., Nussberger, J., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90182-x · Cited by 9
Drug Transporters and Their Role in Tissue Distribution
Dantzig, A. H., Hillgren, K. M., & de Alwis, D. P. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39021-4 · Cited by 7
Poland, D. C. W., Kulik, W., van Dijk, W., Hallemeesch, M. M., Jakobs, C., & de Meer, K. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000018584.66712.2c · Cited by 3
Cited by
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences
Atzrodt, J., Derdau, V., Kerr, W. J., & Reid, M. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201704146 · Cited by 810
Plasma protein binding: From discovery to development
Bohnert, T., & Gan, L.-S. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23614 · Cited by 430
Drug–protein binding: a critical review of analytical tools
Vuignier, K., Schappler, J., Veuthey, J.-L., Carrupt, P.-A., & Martel, S. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3737-1 · Cited by 389
Metadata
- Authors
- Trainor, G. L.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 2
- Issue
- 1
- Pages
- 51-64
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2097688080
- Cited by
- 348
- References
- 78
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.